Kano Therapeutics
Nicholas Gentile is a Senior Research Associate at Kano Therapeutics, with a career encompassing significant roles in biopharmaceutical research and development. Previously, Nicholas served as Associate Scientist II at ElevateBio and as Research Associate II at Vedere Bio II, where a robust downstream purification process for adeno-associated virus (AAV) was developed, featuring a unique enrichment step and effective endotoxin removal. Nicholas's experience also includes work as a Chromatography Technician II at Siemens Healthineers, focusing on GMP monoclonal antibody manufacturing, and positions as Field Technician at Triumvirate Environmental and Cyn Environmental Services. Nicholas holds a Bachelor's degree in Biology from the University of Massachusetts Dartmouth.
This person is not in any teams
Kano Therapeutics
Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures.